Protocol for a scoping review of factors associated with disparities in clinical provision of deep brain stimulation
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
INTRODUCTION: Deep brain stimulation (DBS) can be used to treat several neurological and psychiatric conditions such as Parkinson's disease, epilepsy and obsessive-compulsive disorder; however, limited work has been done to assess the disparities in DBS access and implementation. The goal of this scoping review is to identify sources of disparity in the clinical provision of DBS.
METHODS AND ANALYSIS: A scoping review will be conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-extension for Scoping Reviews methodology. Relevant studies will be identified from databases including MEDLINE/PubMed, EMBASE and Web of Science, as well as reference lists from retained articles. Initial search dates were in January 2023, with the study still ongoing. An initial screening of the titles and abstracts of potentially eligible studies will be completed, with relevant studies collected for full-text review. The principal investigators and coauthors will then independently review all full-text articles meeting the inclusion criteria. Data will be extracted and collected in table format. Finally, results will be synthesised in a table and narrative report.
ETHICS AND DISSEMINATION: No institutional board review or approval is necessary for the proposed scoping review. The findings will be submitted for publication to relevant peer-reviewed journals and conferences.
SCOPING REVIEW REGISTRATION: This protocol has been registered prospectively on the Open Science Framework (https://osf.io/cxvhu).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
BMJ open - 14(2024), 3 vom: 21. März, Seite e079601 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abramson, Tiffany [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Epilepsy |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 27.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjopen-2023-079601 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370037227 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370037227 | ||
| 003 | DE-627 | ||
| 005 | 20240328000254.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjopen-2023-079601 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1351.xml |
| 035 | |a (DE-627)NLM370037227 | ||
| 035 | |a (NLM)38514149 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abramson, Tiffany |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Protocol for a scoping review of factors associated with disparities in clinical provision of deep brain stimulation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a INTRODUCTION: Deep brain stimulation (DBS) can be used to treat several neurological and psychiatric conditions such as Parkinson's disease, epilepsy and obsessive-compulsive disorder; however, limited work has been done to assess the disparities in DBS access and implementation. The goal of this scoping review is to identify sources of disparity in the clinical provision of DBS | ||
| 520 | |a METHODS AND ANALYSIS: A scoping review will be conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-extension for Scoping Reviews methodology. Relevant studies will be identified from databases including MEDLINE/PubMed, EMBASE and Web of Science, as well as reference lists from retained articles. Initial search dates were in January 2023, with the study still ongoing. An initial screening of the titles and abstracts of potentially eligible studies will be completed, with relevant studies collected for full-text review. The principal investigators and coauthors will then independently review all full-text articles meeting the inclusion criteria. Data will be extracted and collected in table format. Finally, results will be synthesised in a table and narrative report | ||
| 520 | |a ETHICS AND DISSEMINATION: No institutional board review or approval is necessary for the proposed scoping review. The findings will be submitted for publication to relevant peer-reviewed journals and conferences | ||
| 520 | |a SCOPING REVIEW REGISTRATION: This protocol has been registered prospectively on the Open Science Framework (https://osf.io/cxvhu) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Epilepsy | |
| 650 | 4 | |a Health Equity | |
| 650 | 4 | |a Health Services Accessibility | |
| 650 | 4 | |a NEUROLOGY | |
| 650 | 4 | |a PSYCHIATRY | |
| 650 | 4 | |a Parkinson-s disease | |
| 700 | 1 | |a Aguero, Rosario |e verfasserin |4 aut | |
| 700 | 1 | |a Arizpe, Angel |e verfasserin |4 aut | |
| 700 | 1 | |a Frank, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Mason, Xenos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2011 |g 14(2024), 3 vom: 21. März, Seite e079601 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:3 |g day:21 |g month:03 |g pages:e079601 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2023-079601 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 3 |b 21 |c 03 |h e079601 | ||